BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28715161)

  • 21. Schedules of Controlled Substances: Placement of MT-45 Into Schedule I. Final order.
    Drug Enforcement Administration, Department of Justice.
    Fed Regist; 2017 Dec; 82(238):58557-9. PubMed ID: 29235771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schedules of controlled substances: temporary placement of three synthetic phenethylamines into Schedule I. Final order.
    Drug Enforcement Administration. Department of Justice
    Fed Regist; 2013 Nov; 78(221):68716-9. PubMed ID: 24236337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Schedules of Controlled Substances: Placement of AH-7921 Into Schedule I. Final order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2016 Apr; 81(72):22023-5. PubMed ID: 27101639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Schedule of controlled substances: placement of tramadol into schedule IV. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2014 Jul; 79(127):37623-30. PubMed ID: 25016619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Schedules of controlled substances: temporary placement of three synthetic cannabinoids into Schedule I. Final order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2013 May; 78(95):28735-9. PubMed ID: 23678676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Schedules of Controlled Substances: Placement of Three Synthetic Phenethylamines Into Schedule I. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2016 Sep; 81(187):66181-4. PubMed ID: 27726316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Schedules of controlled substances: placement of perampanel into Schedule III. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2013 Dec; 78(231):72013-6. PubMed ID: 24294637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Schedules of Controlled Substances: Placement of 10 Synthetic Cathinones Into Schedule I. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2017 Mar; 82(39):12171-7. PubMed ID: 28355044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Schedules of controlled substances: placement of suvorexant into Schedule IV. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2014 Aug; 79(167):51243-7. PubMed ID: 25167596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Schedules of Controlled Substances: Placement of Eluxadoline Into Schedule IV. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2015 Nov; 80(218):69861-4. PubMed ID: 26567437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Schedules of Controlled Substances: Placement of PB-22, 5F-PB-22, AB-FUBINACA and ADB-PINACA into Schedule I. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2016 Sep; 81(172):61130-3. PubMed ID: 27632803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Schedules of Controlled Substances: Placement of Thiafentanil Into Schedule II. Interim final rule with request for comments.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2016 Aug; 81(166):58834-40. PubMed ID: 27568479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Schedules of Controlled Substances: Placement of AB-CHMINACA, ABPINACA and THJ-2201 Into Schedule I. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2017 Oct; 82(198):47971-4. PubMed ID: 29035496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Schedules of Controlled Substances: Extension of Temporary Placement of Three Synthetic Phenethylamines in Schedule I. Final order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2015 Nov; 80(219):70657-9. PubMed ID: 26567439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Schedules of Controlled Substances: Placement of UR-144, XLR11, and AKB48 into Schedule I. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2016 May; 81(91):29142-5. PubMed ID: 27192731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB- CHMICA and MDMB-FUBINACA) Into Schedule I. Notice of Intent.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2016 Dec; 81(245):93595-9. PubMed ID: 28068047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Schedules of controlled substances: rescheduling of hydrocodone combination products from schedule III to schedule II. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2014 Aug; 79(163):49661-82. PubMed ID: 25167591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2011 Oct; 76(204):65371-5. PubMed ID: 22016903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Schedules of controlled substances: removal of naloxegol from control. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2015 Jan; 80(15):3468-70. PubMed ID: 25730920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Schedules of Controlled Substances: Extension of Temporary Placement of PB-22, 5F-PB-22, AB-FUBINACA and ADB-PINACA in Schedule I of the Controlled Substances Act. Final order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2016 Feb; 81(24):6175-7. PubMed ID: 26859904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.